I promise

"I promise, Suzy... Even if it takes the rest of my life." -Nancy G. Brinker, Founder of Susan G. Komen for the Cure

What is TNBC

WHAT IS TRIPLE NEGATIVE BREAST CANCER?

Just in recent years, Triple Negative Breast Cancer (TNBC) has sparked interest in the news where instead of calling the tumor as ER-negative, PR-negative, and HER2-negative; researchers began using the shorthand term, "Triple Negative," dubbed the "new type" of breast cancer. Being Triple Negative, you don't have a targeted therapy and your only treatment option is chemotherapy.

Triple Negative Breast Cancer is seen in about 15% of all breast cancers. TNBC is a very aggressive cancer that tends to strike younger women, pre-menopause, especially among African-American women and women who have BRCA1 mutations. The tumor tends to be fast growing and is less likely to show up on an annual mammogram. TNBC is more likely to metastasis early on; has a high rate of recurrence in the first 2-3 years from diagnosis and has a poorer prognosis than other types of breast cancer due to lack of specific, targeted treatment for TNBC.

Tuesday, March 29, 2011

Triple Negative Breast Cancer Is Rare But Aggressive - WTOL.com - Toledo's News Leader |


Triple negative breast cancer is rare but aggressive - WTOL.com - Toledo's News Leader | (click to view video)







By Jonathan Walsh -
TOLEDO, OH (WTOL) - It's aggressive. It's rare. And sometimes, it doesn't show up on a mammogram.
A special information session was held Monday night on triple negative breast cancer. This variation only affects about 15 percent of breast cancer patients, but it attacks quickly.
Survivors asked questions about the disease to help understand more about what to expect. They also asked whether their daughters should have genetic testing.
Melissa Paskvan is a triple negative patient who attended. "I knew I had aggressive cancer," she said. "I knew it was rare, and I knew there was no treatment for it besides chemo."



Total Pageviews



"click image to link"